Navigation Links
Neuronal conduction of excitation without action potentials based on ceramide production
Date:9/11/2007

Researchers from the Laboratoire de Physiologie Neurovg tative (CNRS-INRA-Universit Paul C zanne), the Laboratoire de Chimie Biologique Applique (INRA-Universit Paul Czanne) and from the D partement Lipoprotines et M diateurs Lipidiques (INSERM, Hopital Purpan Toulouse), and in particular Professor Jean-Pierre Miolan, Dr Jean-Pierre Niel, Directeur de Recherche CNRS, Dr Franois Terc , Charg de Recherche INSERM, Dr Abel Hiol Ma tre de confrence and Dr Caroline Fasano, author in 2004 of the PhD thesis Sphingolipides et physiologie des ganglions sympathiques pr vertbraux , have succeeded in demonstrating that a neuronal network in mammals can work perfectly with a mode of conduction of excitation that is independent of action potentials.

This new mechanism involves molecules known to play a role in numerous mechanisms of cell functioning, but not hitherto in conduction of excitation. To elucidate this mechanism, the teams have used a model of integrated physiology on an in vitro preparation in the mammal. This study has been performed using neuropharmacological and biochemical techniques.

This study, reporting the first discovery of conduction of excitation without action potentials, opens up new perspectives for research by breaking away from the classic concept of neuronal functioning. The neurons would thus be fitted with two modes of conduction of excitation, fast and slow, which might be used in different circumstances. This would have important consequences in the fields of physiological research and clinical practice.


'/>"/>
Contact: Lise Grandperrin
lise.grandperrin@univ-cezanne.fr
33-044-217-2791
Public Library of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Neuronal traffic jam marks early Alzheimers disease
2. Molecular Partners Required For Appropriate Neuronal Gene Repression
3. Neuronal cell cultures kept on the straight and narrow
4. Taking the wrinkles out of motoneuronal disease
5. Cocaine high caused by interference in neuronal receiving stations
6. Widely used iron nanoparticles exhibit toxic effects on neuronal cells
7. Proteasome activator enhances survival of Huntingtons disease neuronal model cells
8. Striking the right balance between excitation and inhibition
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
11. Two chemicals boost immune cells ability to fight HIV without gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2016)... 2016   Neurotechnology , a provider of ... announced that the MegaMatcher On Card fingerprint matching ... the NIST Minutiae Interoperability Exchange (MINEX) III ... steps of the evaluation protocol. ... of fingerprint templates used to establish compliance of ...
(Date:11/17/2016)... 2016 Global Market Watch: Primarily supported ... Population-Based Banks and Academics) market is to witness a value ... shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% ... the analysis period 2014-2020. North America ... by Europe at 9.56% respectively. ...
(Date:11/16/2016)... SANTA CLARA, Calif. , Nov. 16, 2016 /PRNewswire/ ... company enhancing user experience and security for consumer ... provider for the financial and retail industry, today ... more secure and convenient way to authenticate users ... now uses Sensory,s TrulySecure™ software which ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... and ANN ARBOR, Mich. ... held biopharmaceutical company developing breakthrough immune modulatory medicines, announced ... of the Company,s lead therapeutic candidate, LYC-30937- E nteric ... often a debilitating skin disease that is estimated to ... the United States , with approximately 1.5 - ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... and resource recovery solutions for industrial facilities, today announced that one of the ... first to use Cambrian’s novel water-energy purchase agreement (WEPA). Under the WEPA, a ...
(Date:12/7/2016)... ... December 07, 2016 , ... JULABO USA is inviting ... The new website has been designed to provide the best user-friendly experience coupled ... access detailed product information, read educational industry content as well as share information ...
Breaking Biology Technology: